股本结构
单位：万股
| 公告日期 | 2023-02-27 | 2023-02-27 | 2022-11-08 | 2022-11-08 | 2022-09-30 | 2022-09-06 |
|---|---|---|---|---|---|---|
| 证券总股本 | 23651.12 | 23637.13 | 23594.88 | 23579.13 | 23575.22 | 24064.13 |
| 普通股本 | 23651.12 | 23637.13 | 23594.88 | 23579.13 | 23575.22 | 24064.13 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2023-01-31 | 2022-12-31 | 2022-10-31 | 2022-09-30 | 2022-09-26 | 2022-08-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2023-02-27 | 23651.12 | 未披露 | 定期报告 | 2023-01-31 |
| 2023-02-27 | 23637.13 | 未披露 |
更多>>
From January 1, 2022 to December 31, 2022
Vesting of restricted stock units, net of shares withheld to cover payroll taxes
Proceeds from exercises of stock options
Equity-based compensation
Issuance of Class A common stock under stock purchase plan
Issuance of Class A common stock in connection with Caravan Health acquisition, net of tax
Exchange of LLC units
|
2022-12-31 |
| 2022-11-08 | 23594.88 | 未披露 | 定期报告 | 2022-10-31 |
| 2022-11-08 | 23579.13 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Exchange of LLC units
Vesting of restricted stock units, net of shares withheld to cover payroll taxes
Proceeds from exercises of stock options
Equity-based compensation
|
2022-09-30 |
| 2022-09-30 | 23575.22 | 未披露 | 定期报告 | 2022-09-26 |
| 2022-09-06 | 24064.13 | 未披露 | 定期报告 | 2022-08-31 |
| 2022-08-04 | 23444.06 | 未披露 | 定期报告 | 2022-07-31 |
| 2022-08-04 | 23417.58 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Vesting of restricted stock units
Proceeds from exercises of stock options
Issuance of Class A common stock under stock purchase plan
Exchange of LLC units
Equity-based compensation
|
2022-06-30 |
| 2022-05-31 | 23387.97 | 未披露 | 定期报告 | 2022-05-27 |
| 2022-05-05 | 23368.95 | 未披露 | 定期报告 | 2022-04-30 |
| 2022-05-05 | 23354.56 | 未披露 |
更多>>
From January 1, 2022 to March 31, 2022
Vesting of restricted stock units
Proceeds from exercises of stock options
Exchange of LLC units
Issuance of Class A common stock in connection with Caravan Health acquisition
Equity-based compensation
|
2022-03-31 |
| 2022-04-05 | 23341.88 | 未披露 | 定期报告 | 2022-03-21 |
| 2022-03-03 | 22801.75 | 未披露 | 定期报告 | 2022-02-28 |
| 2022-03-03 | 22782.61 | 未披露 |
更多>>
From January 1, 2021 to December 31, 2021
Initial effect of the Reorganization Transactions and IPO on noncontrolling interests
Issuance of Class A common stock in IPO, net of issuance costs
Equity-based compensation subsequent to Reorganization Transactions
Proceeds from exercises of stock options
Issuance of Class A common stock under stock purchase plan
Exchange of LLC units
|
2021-12-31 |
| 2021-11-10 | 22690.29 | 未披露 | 定期报告 | 2021-10-31 |
| 2021-11-10 | 22683.83 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Proceeds from exercises of stock options
Exchange of LLC units
Equity-based compensation subsequent to Reorganization Transactions
|
2021-09-30 |
| 2021-08-11 | 22594.16 | 未披露 | 定期报告 | 2021-07-31 |
| 2021-08-11 | 22593.44 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Proceeds from exercises of stock options
Equity-based compensation subsequent to Reorganization Transactions
|
2021-06-30 |
| 2021-05-12 | 22562.54 | 未披露 | 定期报告 | 2021-04-30 |
| 2021-05-12 | 22559.02 | 未披露 |
更多>>
From January 1, 2021 to March 31, 2021
Initial effect of the Reorganization Transactions and IPO on noncontrolling interests
Issuance of Class A common stock in IPO, net of issuance costs
Proceeds from exercises of stock options
Equity-based compensation subsequent to Reorganization Transactions
|
2021-03-31 |
| 2021-03-25 | 22539.71 | 未披露 | 定期报告 | 2021-03-01 |
| 2021-02-12 | 22515.19 | 未披露 |
更多>>
1.Class A common stock offered by the company 23,500,000 shares
On February 11, 2021, Signify Health’s Class A common stock began trading on the New York Stock Exchange under the ticker symbol SGFY in connection with its initial public offering (IPO) of 27,025,000 shares of Class A common stock (including the full exercise of the underwriters’ over allotment of shares), at a price to the public of $24.00 per share. Signify Health received net proceeds of approximately $609.7 million after deducting underwriting discounts and commissions and before deducting offering expenses.
|
2021-02-11 |
From January 1, 2022 to December 31, 2022
Vesting of restricted stock units, net of shares withheld to cover payroll taxes
Proceeds from exercises of stock options
Equity-based compensation
Issuance of Class A common stock under stock purchase plan
Issuance of Class A common stock in connection with Caravan Health acquisition, net of tax
Exchange of LLC units
From June 30, 2022 to September 30, 2022
Exchange of LLC units
Vesting of restricted stock units, net of shares withheld to cover payroll taxes
Proceeds from exercises of stock options
Equity-based compensation
From March 31, 2022 to June 30, 2022
Vesting of restricted stock units
Proceeds from exercises of stock options
Issuance of Class A common stock under stock purchase plan
Exchange of LLC units
Equity-based compensation
From January 1, 2022 to March 31, 2022
Vesting of restricted stock units
Proceeds from exercises of stock options
Exchange of LLC units
Issuance of Class A common stock in connection with Caravan Health acquisition
Equity-based compensation
From January 1, 2021 to December 31, 2021
Initial effect of the Reorganization Transactions and IPO on noncontrolling interests
Issuance of Class A common stock in IPO, net of issuance costs
Equity-based compensation subsequent to Reorganization Transactions
Proceeds from exercises of stock options
Issuance of Class A common stock under stock purchase plan
Exchange of LLC units
From June 30, 2021 to September 30, 2021
Proceeds from exercises of stock options
Exchange of LLC units
Equity-based compensation subsequent to Reorganization Transactions
From March 31, 2021 to June 30, 2021
Proceeds from exercises of stock options
Equity-based compensation subsequent to Reorganization Transactions
From January 1, 2021 to March 31, 2021
Initial effect of the Reorganization Transactions and IPO on noncontrolling interests
Issuance of Class A common stock in IPO, net of issuance costs
Proceeds from exercises of stock options
Equity-based compensation subsequent to Reorganization Transactions
1.Class A common stock offered by the company 23,500,000 shares
On February 11, 2021, Signify Health’s Class A common stock began trading on the New York Stock Exchange under the ticker symbol SGFY in connection with its initial public offering (IPO) of 27,025,000 shares of Class A common stock (including the full exercise of the underwriters’ over allotment of shares), at a price to the public of $24.00 per share. Signify Health received net proceeds of approximately $609.7 million after deducting underwriting discounts and commissions and before deducting offering expenses.